Abstract
Back to table of contents Previous article Next article Government NewsFull AccessFederal Office Gives Psychiatrist Key Addiction-Research PostEve BenderEve BenderSearch for more papers by this authorPublished Online:3 Jan 2003https://doi.org/10.1176/pn.38.1.0004aThe White House Office of National Drug Control Policy (ONDCP) Counterdrug Technology Assessment Center (CTAC) has chosen an APA member as one of the recipients of a $5.85 million grant to investigate the genetic factors that predispose people to addiction.Patricia Ordorica, M.D., is associate chief of staff for mental health and behavioral sciences at the James A. Haley VA Hospital in Tampa and clinical director of the CTAC Drug Addiction Study. She is also the director of addictive disorders and associate professor of psychiatry at the University of South Florida in Tampa.In APA, Ordorica is chair of the APA/CMHS Minority Fellowship Selection and Advisory Committee, vice chair of APA’s Scientific Program Committee, and a member of the Vestermark Award Corresponding Committee.As clinical director of the study, Patricia Ordorica, M.D., will oversee all administrative and clinical aspects of the drug addiction treatment research, and with principal investigator Michael Mullan, M.D., Ph.D., supervise the research components and operations. Mullan is director of the Roskamp Institute, a research facility in Tampa.Patients with substance use disorders will be recruited from the veterans hospital and other CTAC-funded research centers in a sample that will top 1,000 patients. The research team will use the ONDCP funding to purchase the latest gene chip and protein analysis technology, which will enable them to study hundreds of thousands of human genes and the proteins expressed by those genes.By identifying the genes and proteins activated by different drugs of abuse, the researchers hope to design a therapeutic intervention that will ultimately disrupt the addiction process. ▪ ISSUES NewArchived
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
